Specific symptoms documented included diarrhea, flatulence, nausea, and increased appetite
Results take longer, which can lead to impatience or discontinuation
Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial
Clinical studies show patients can expect an average of 1015% body weight reduction over one year, with improved metabolic health and reduced risk of obesity-related conditions
Dai X, Stanilka JM, Rowe CA, Esteves EA, Nieves C, Spaiser SJ, et al
You can also compare workflows in our semaglutide progress tracking guide and broader GLP-1 progress guide if you are weighing different tracking needs.